Buscopan compositum-injectie I.M. 4 mg/ml + 500 mg/ml oplossing voor injectie voor runderen, varkens en honden
Buscopan compositum-injectie I.M. 4 mg/ml + 500 mg/ml oplossing voor injectie voor runderen, varkens en honden
Authorised
- Hyoscine butylbromide
- Metamizole sodium
Product identification
Medicine name:
Buscopan compositum-injectie I.M. 4 mg/ml + 500 mg/ml oplossing voor injectie voor runderen, varkens en honden
Active substance:
- Hyoscine butylbromide
- Metamizole sodium
Target species:
-
Cattle
-
Pig
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Hyoscine butylbromide4.00/milligram(s)1.00millilitre(s)
-
Metamizole sodium500.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal15day
-
-
Pig
-
Meat and offal15day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA03DB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Available in:
-
Netherlands
Package description:
- Available only in Dutch
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 8944
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 29/11/2024